Redsense Medical AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 1.73 million compared to SEK 7 million a year ago. Revenue was SEK 2.69 million compared to SEK 7.05 million a year ago.

Net loss was SEK 2.64 million compared to net income of SEK 0.413 million a year ago. Basic loss per share from continuing operations was SEK 0.19 compared to basic earnings per share from continuing operations of SEK 0.03 a year ago.